UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

MLA

Pim Ittiphakorn, et al. “UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Attention‐deficit/Hyperactivity Disorder.” Neuropsychopharmacology Reports, vol. 43, no. 4, Dec. 2023, pp. 596–606. EBSCOhost, https://doi.org/10.1002/npr2.12400.

APA

Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, & Mikael H. Sodergren. (2023). UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder. Neuropsychopharmacology Reports, 43(4), 596–606. https://doi.org/10.1002/npr2.12400

Chicago

Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, and Mikael H. Sodergren. 2023. “UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Attention‐deficit/Hyperactivity Disorder.” Neuropsychopharmacology Reports 43 (4): 596–606. doi:10.1002/npr2.12400.